Clinical Trial Update: A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Multiple Intravenous Doses of N-acetylcysteine (NAC) in Chinese Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of intravenous N-acetylcysteine in healthy volunteers, completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Disorders

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Zambon SpA | Conditions: Respiratory Tract Disorders | Phase 1 | Status: COMPLETED | Results posted: 2021-01-20